Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Adaptive forward error corrector and method thereof, and TDD radio repeating apparatus using the same










Image Number 3 for United States Patent #7826801.

An adaptive feedback estimation and cancellation (AFEC) apparatus includes: a controller for generating and outputting control information by using a synchronization signal from an external synchronization acquisition unit and base station information, in order to remove a feedback signal that exists in a forward/reverse repeater signal to be repeated and then send the forward/reverse repeater signal; a first feedback prediction canceller for adaptively removing a feedback signal that exists in the forward repeater signal based on the control information from the controller and automatically adjusting the gain of the forward repeater signal; and a second feedback prediction canceller for adaptively removing a feedback signal that exists in the reverse repeater signal based on the control information from the controller and automatically controlling the gain of the reverse repeater signal.








 
 
  Recently Added Patents
Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
Data storage device and block selection method for a flash memory
Sock
Systems and methods for identifying malicious domains using internet-wide DNS lookup patterns
Surveillance apparatus and method for wireless mesh network
Rapid glycopeptide optimization via neoglycosylation
Methods of forming semiconductor devices having diffusion regions of reduced width
  Randomly Featured Patents
Resin composition
Read-preferred SRAM cell design
Optical disk apparatus wherein recording clock signal is stopped being supplied to semiconductor laser drive circuit on optical pickup during reproduction operation
System for protection of plants from pathogens using alkamides
Vibration-proof tungsten wire
Process for the preparation of loratadine
Two-wheeled skateboard
V-Mos field effect transistor
Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
Nitrogen-based camptothecin derivatives